Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers.

× No keyword cloud information.

5 in total

Review 1. New knowledge of the mechanisms of sorafenib resistance in liver cancer.

Authors: Yan-Jing Zhu; Bo Zheng; Hong-Yang Wang; Lei Chen
Journal: Acta Pharmacol Sin Date: 2017-03-27 Impact factor: 6.150

Review 2. New progress of non-surgical treatments for hepatocellular carcinoma.

Authors: Ji-Wen Cheng; Yi Lv
Journal: Med Oncol Date: 2013-01-06 Impact factor: 3.064

3. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.

Authors: Lei Zhang; Faming Gong; Fang Zhang; Jing Ma; Peidong Zhang; Jun Shen
Journal: Int J Nanomedicine Date: 2013-04-17

4. Sorafenib improves the postoperative effect of early stage renal cell carcinoma.

Authors: Taiyang Liu; Jie Li; Xiuhua Wen; Zhang Hui; Gui Qi
Journal: Oncol Lett Date: 2016-10-12 Impact factor: 2.967

5. N⁶-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling.

Authors: Junjie Xu; Zhe Wan; Minyue Tang; Zhongjie Lin; Shi Jiang; Lin Ji; Kirill Gorshkov; Qijiang Mao; Shunjie Xia; Dong Cen; Junhao Zheng; Xiao Liang; Xiujun Cai
Journal: Mol Cancer Date: 2020-11-23 Impact factor: 27.401